UK pharma’s POM product-information estates are more fragmented than many teams may realise
Genetic Digital’s UK POM Product-Information Estate Benchmark 2026 assessed 100 UK prescription medicine companies and found a market at very different stages of digital maturity. The findings show why product visibility, audience routing, prescribing information access and findability now need more strategic attention from pharma teams.
AI Is Not the Problem. Weak Pharma Content Workflows Are.
AI can help pharma teams draft, structure and repurpose content faster. But it cannot fix weak briefs, unclear audiences, poor source material or fragile approval workflows. This article explores why AI-assisted pharma content often becomes generic, slow to approve or difficult to govern and why better content workflows matter more than better prompts.
Compliance is not the website bottleneck. Your governance model is.
Pharma teams often blame compliance when website projects slow down. In reality, weak governance is usually the bigger issue. Here is what is really causing the delay, and what better governance looks like in practice.
Clicks Don’t Prove Confidence: What Pharma Teams Should Really Be Measuring
Clicks, sessions and conversions still matter, but they rarely reflect how confidence is built in pharma buying journeys. This article explores what life sciences teams should really be measuring when websites are used for evaluation, scrutiny and internal decision-making.
What healthcare teams should fix before the new MHRA AI framework lands
AI readiness in healthcare is no longer just a future policy issue. For teams building websites, web platforms and regulated medical device apps, it is already a product governance challenge spanning intended use, output review, clinical safety, evidence and post-market monitoring.
Why ABM in Pharma Lives or Dies on the Website
ABM in pharma doesn’t fail in the campaign platform — it fails on the website. This article explores why thinking beyond the click is critical in regulated digital journeys.
The Rise of AI in Life Sciences & Pharma Marketing: What’s Coming in 2026
AI has evolved faster than any digital technology we’ve seen. Here’s how life sciences and pharma marketing teams can prepare for the major shifts coming in 2026.
From Lab Bench to Launch: The Digital Readiness Playbook for Life Sciences Start-ups
Many early-stage life sciences ventures focus on science but overlook digital foundations. This guide shows biotech, medtech, and pharma startups how to build a credible, strategic online presence to support funding, growth, and recruitment — even before launch.
Your New Healthcare Website: Are You Asking for the Right Things?
Excited about launching a new healthcare or pharma website? Make sure you’re focusing on the right priorities. Discover how a strategy-first approach can save time, budget, and deliver better results.
Biotech Brands: Why Your Digital Presence Matters More Than Ever in 2025
Showcasing innovative science? Don’t let outdated digital assets hold you back. Learn why a modern, compliant and investor-ready digital presence is essential for biotech brands looking to grow, fundraise and stand out.